Eu­rope buys 54,000 more dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine as cas­es in­crease

The EU is back for more dos­es of mon­key­pox vac­cines af­ter see­ing thou­sands of more cas­es.

The Eu­ro­pean Com­mis­sion an­nounced Mon­day that it reached a deal with Bavar­i­an Nordic to buy an ad­di­tion­al 54,000 dos­es of the biotech’s mon­key­pox vac­cine af­ter a sub­stan­tial in­crease in mon­key­pox cas­es in the con­ti­nent.

This or­der and oth­ers pushed Bavar­i­an Nordic on Mon­day to al­so re­up its 2022 rev­enue guid­ance, which is now ex­pect­ed to be be­tween $368 mil­lion and $396 mil­lion (pre­vi­ous­ly it was es­ti­mat­ed to be be­tween $314 mil­lion and $341 mil­lion).

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN